Bcl-2-mediated resistance in CLL may also be overcome by small molecular inhibitors of the anti-apoptotic XIAP (X-linked inhibitor of apoptosis) when exposed to TRAIL [62, 63]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.